0.00
100.00%
-1.82
Mymd Pharmaceuticals Inc (MYMD) 財務データ
損益計算書
四半期ごと
*すべての数値は百万単位です
期間終了日 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
期間の長さ | 3 か月 | 3 か月 | 3 か月 | 3 か月 | 3 か月 |
Research and Development |
59.50%
1.1989
|
2.9606 | 1.9123 | 2.2244 | 0.7704 |
Operating Income/Loss |
43.27%
-2.7846
|
-4.9085 | -3.8426 | -5.7816 | -2.5903 |
Nonoperating Income/Loss |
375.66%
-7.0154
|
2.545 | 7.8856 | 1.614 | 1.0786 |
Income/Loss From Continuing Operations Before Tax |
314.63%
-9.80
|
-2.3636 | 4.043 | -4.1677 | -1.5117 |
Income/Loss From Continuing Operations After Tax |
50.94%
-9.80
|
-6.4926 | 4.043 | -4.1677 | -1.5117 |
Net Income/Loss
|
314.63%
-9.80
|
-2.3636 | 4.043 | -4.1677 | -1.5117 |
Preferred Stock Dividends And Other Adjustments |
52.46%
1.2019
|
2.528 | 1.1581 | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
105.33%
2.1411
|
-40.17 | 44.95 | 40.35 | 39.79 |
Basic Earnings Per Share |
2.10%
-5.14
|
-5.25 | 0.06 | -0.11 | -0.04 |
Diluted Earnings Per Share |
2.10%
-5.14
|
-5.25 | 0.06 | -0.11 | -0.05 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
52.46%
1.2019
|
2.528 | 1.1581 | - | - |
大文字化:
|
ボリューム (24 時間):